DUBLIN–(BUSINESS WIRE)–The “Global
Non-Melanoma Skin Cancer Clinical Trial Pipeline Highlights – 2019”
report has been added to ResearchAndMarkets.com’s
offering.
Non-Melanoma Skin Cancer Pipeline Highlights – 2019 provides the most
up-to-date information on key pipeline products in the global
Non-Melanoma Skin Cancer market.
It covers emerging therapies for Non-Melanoma Skin Cancer in active
clinical development stages including early and late stage clinical
trials. The pipeline data presented in this report helps executives for
tracking competition, identifying partners, evaluating opportunities,
formulating business development strategies, and executing in-licensing
and out-licensing deals.
Clinical Trial Stages:
The report provides Non-Melanoma Skin Cancer pipeline products by
clinical trial stages including both early and late stage development –
phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical
trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Non-Melanoma Skin Cancer pipeline products by their
dominant mechanism of action/drug class. This helps executives
categorize products based on their drug class and also assess the
strengths and weaknesses of compounds.
Company:
The report provides Non-Melanoma Skin Cancer pipeline products by the
company.
Short-term Launch Highlights:
Find out which Non-Melanoma Skin Cancer pipeline products will be
launched in the US and Ex-US till 2024.
Key Topics Covered:
1. Non-Melanoma Skin Cancer Pipeline by Stages
2. Non-Melanoma Skin Cancer Phase 3 Clinical Trial Insights
3. Non-Melanoma Skin Cancer Phase 2 Clinical Trial Insights
4. Non-Melanoma Skin Cancer Phase 1 Clinical Trial Insights
5. Non-Melanoma Skin Cancer Preclinical Research Insights
6. Non-Melanoma Skin Cancer Discovery Stage Insights
7. Appendix
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/e6ino1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Skin
Cancer Drugs, Dermatological
Drugs